In Asia, there are currently four vaccines in late stage clinical trials. These vaccines protect against EV-A71, an enterovirus very similar to EV-D68, the main culprit of Acute Flaccid Myelitis in the US.
In Asia, there are currently four vaccines in late stage clinical trials. These vaccines protect against EV-A71, an enterovirus very similar to EV-D68, the main culprit of Acute Flaccid Myelitis in the US.